RyanUngaroMDMS
Gastroenterology • New York, NYInflammatory Bowel Disease
Associate Professor, Gastroenterology
Dr. Ungaro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Place
New York, NY 10029Phone+1 212-241-8100
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2013 - 2016- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalChief Residency, Internal Medicine, 2012 - 2013
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2012
- Icahn School of Medicine at Mount SinaiClass of 2009
Certifications & Licensure
NY State Medical License 2011 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Crohn's and Colitis Foundation Career Development Award 2017
- Howard Hughes Medical Institute (HHMI) Research Training Fellowship
Publications & Presentations
PubMed
- Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study.Scott D Lee, Severine Vermeire, Ryan Ungaro, Aisha Vadhariya, Frederick Durand
The American Journal of Gastroenterology. 2025-03-13 - Novel Outcomes in Inflammatory Bowel Disease.Vipul Jairath, Neeraj Narula, Ryan C Ungaro, Itzel Romo Bautista, Shashi Adsul
Journal of Crohn's & Colitis. 2025-03-13 - Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study.Jalpa Devi, Anthony Xu, Molly Stone, Anish Patel, Abdul Khan
Clinical Gastroenterology and Hepatology. 2025-03-07
Journal Articles
- Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel DiseasesRyan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences
Press Mentions
Combo Therapy in IBD: Is De-Escalation Possible After 1 Year?February 14th, 2023- A Review of "Controversies in IBD: Shark Tank Edition"January 30th, 2023
- AGA Risk Assessment Tool Aids Patient, Physician Decision-Making for Crohn’s TherapyJanuary 25th, 2023
- Join now to see all
Grant Support
- Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2025
- Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2025
- Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2025
- Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2025
Professional Memberships
- Member
- Member
- Member
- Crohn's and Colitis Foundation of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
